Clinical trial · Observational
Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
A Retrospective Study to Extend the Maximum Maintenance Flushing Interval for Ports With Distally Valved Catheters
NCT01586026CI-TRIAL-00023604DISTALterminatedResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Insufficient number of adverse events
Summary
Brief summary (as posted)
This study is to compare the rate of adverse events in subjects with maintenance flushes greater than 28 days.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (3)
- label
- Group A
- description
- Maintenance flushes at days 1-28
- label
- Group B
- description
- Maintenance flushes at days 29-56
- label
- Group C
- description
- Maintenance flushes at days 57+
Primary outcomes (1)
- measure
- The Rate of Adverse Events in Group A (1-28 Day Flushing Interval) Versus Extended Accession Intervals in Group B (29-56 Day Flushing Interval), and Group C (57+ Days).
- timeFrame
- 100 days
- description
- Subjects' maintenance flush intervals were collected by calculating the number of days since a previous flush. A total of 1,035 maintenance flush intervals were recorded at all sites. The numbers of flushing intervals available for analysis are 1,035 representing 49,696 patient days were recorded in 171 subjects.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Male or female, age ≥ 21 years * Subject has an implanted Bard port with a distally-valved catheter * Subject has maintenance port flushes with heparin/heparinized saline or normal saline * Subject is post infusional cancer therapy (solid tumor or hematologic) * Subject has signed a HIPAA Authorization to use and disclose PHI Exclusion Criteria: * Subject is having port maintenance flushes/locks with citrate.
References
Publications (0)
Data not yet available
No reference posted for this study.